Hester Biosciences Ltd share price logo

Hester Biosciences Ltd

NSE: HESTERBIO

BSE: 524669

Small Cap

Pharma Sector

₹2156.70

-15.10

(-0.70%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Hester Biosciences shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-42%

Searches for Hester Biosciences on INDmoney have decreased by 42% over the last 30 days.

Key Events for Hester Biosciences

Last Dividend Declared

₹11.00 per share, declared on 15/05/2026

View Dividend History

Hester Biosciences Stock Performance

as on September 16, 2026 at 7:45 pm IST

  • Day's Low

    Day's High

    ₹2,130.00
    ₹2,222.50
    downward going graph

    1.24%

    Downside

    3.05%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,239.30
    ₹2,683.60
    downward going graph

    42.54%

    Downside

    24.43%

    Upside

    downward going graph

Hester Biosciences share price movements today

Previous Close
₹2,171.80
Open
₹2,156.70
Volume
3,423.00
Upper Circuit
₹2,606.10
Lower Circuit
₹1,737.50
Day's Low - High
₹2,130.00 - ₹2,222.50
52 Week Low - High
₹1,239.30 - ₹2,683.60

Hester Biosciences Historical Returns

1 Month Return
-10.17 %
3 Month Return
+ 5.71 %
1 Year Return
+ 5.27 %
3 Year Return
+ 27.51 %
5 Year Return
-12.94 %

Hester Biosciences Fundamentals

as on September 16, 2026 at 2:15 pm IST

Market Cap

₹1,847.52 Cr

Return on Equity (ROE)

14.39

PE Ratio (TTM)

14.07

Return on capital employed (ROCE)

15.28

Industry PE ratio

51.81

Beta (LTM)

0.74

P/B Ratio

2.79

Dividend Yield

0.87

PEG Ratio

0.12

Quarterly Earnings Growth YOY

459.13

EPS (TTM)

67.57

Book Value

423.46

Hester Biosciences Stock Valuation

as on September 16, 2026 at 2:15 pm IST

Hester Biosciences in the last 5 years

  • Overview

  • Trends

Lowest (12.97x)

July 8, 2026

Today (14.07x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (124.52x)

July 26, 2024

LowHigh

Today’s Price to Earnings Ratio: 14.07x

Hester Biosciences Technical Analysis

Track how Hester Biosciences technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish5
Bullish7
Neutral3

Oscillators

Name

Value

Action

MACD level (12,26)
0.64
Bearish
CCI (20)
-12.12
Neutral
RSI (14)
57.02
Neutral
Momentum (10)
0.4
Neutral
ADI (14)
76.16
Bullish
Ultimate Oscillator (7,14,28)
15.64
Bearish

Moving Averages

Name

Value

Action

SMA (20)
2158.27
Bearish
EMA (20)
2157.52
Bullish
VWMA (20)
2158.07
Bearish
SMA (50)
2155.51
Bullish
EMA (50)
2156.64
Bullish
SMA (200)
2157.16
Bullish
EMA (200)
2158.18
Bearish
KAMA (200)
2156.24
Bullish
DEMA (200)
2151.59
Bullish

Hester Biosciences Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hester Biosciences with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Hester Biosciences Ltd image
Hester Biosciences Ltd
NA1,847.52-2.59%0.7157332
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Hester Biosciences Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
70.46
66.98
79.26
82.27
83.69
63.22
81.93
84.11
70.97
77.42
100.11
77.24
Other Income
5.91
2.2
4.63
2.09
2.8
8.78
-5.64
3.37
11.88
1.98
1.77
89.03
Total Income
76.36
69.18
83.88
84.35
86.49
72
76.29
87.47
82.85
79.4
101.88
166.27
Expenses
57.24
56.83
63.33
64.62
64.53
58.16
62.74
61.29
59.25
59.62
65.78
54.47
Operating Profit
13.22
10.15
15.93
17.65
19.16
5.06
19.19
22.82
11.72
17.8
34.33
22.77
Operating Profit Margin %
18.76%
15.15%
20.1%
21.45%
22.89%
8%
23.42%
27.13%
16.51%
22.99%
34.29%
29.48%
Profit Before Interest, Tax and Depreciation
19.12
12.35
20.55
19.74
21.96
13.85
13.54
26.18
23.6
19.78
36.1
111.81
Interest
8.08
2.19
6.94
5.01
5.89
-3.81
5.62
1.81
2.21
1.82
5.1
3.08
Depreciation
4.28
3.75
3.74
4.13
4.2
4.29
4.18
4.18
4.35
4.43
5.91
7.04
Profit Before Tax
6.76
6.41
9.87
10.6
11.87
13.37
3.74
20.19
17.04
13.53
25.09
101.69
Tax Paid
2.72
2.4
3.47
3.11
3.48
1.96
2.2
2.9
2.71
4.22
8.54
4.95
Profit After Tax
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
9.31
16.55
96.73
Total Net profit including share of profit / Loss from associate company
4.04
4.02
6.4
7.49
8.39
11.41
1.54
17.3
14.33
9.31
16.55
96.73
EPS
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
19.45
113.71
Actual EPS
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
19.45
113.71
Adjusted EPS
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
19.45
113.71
Diluted EPS
4.75
4.73
7.52
8.8
9.86
13.41
1.82
20.33
16.85
10.94
19.45
113.71

Hester Biosciences Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
132.6
178.07
183.27
214.33
235.01
266.09
304.55
311.1
332.6
Other Income
2.55
7.21
6.37
4.68
14.16
19.56
15.25
8.02
18.99
Total Income
138.49
185.28
189.63
219.02
249.17
285.65
319.79
319.13
351.59
Expenses
88.68
110.03
127.87
149
175.02
215.48
250.89
250.05
245.94
Operating Profit
43.92
68.04
55.4
65.33
59.99
50.61
53.66
61.05
86.66
Operating Profit Margin %
33.12%
38.21%
30.23%
30.48%
25.53%
19.02%
17.62%
19.62%
26.06%
Profit Before Interest, Tax and Depreciation
49.82
75.25
61.77
70.02
74.15
70.17
68.9
69.08
105.65
Interest
4.04
6.63
7.37
6.6
4.06
9.32
19.78
12.7
10.93
Depreciation
9.66
11.76
13.07
13.31
16.58
20.7
17.17
16.8
18.88
Profit Before Tax
36.12
56.86
41.33
50.11
53.51
40.15
31.95
39.58
75.84
Tax Paid
13.06
16.16
10.33
15.41
14.01
12.12
10.79
10.74
18.35
Profit After Tax
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
57.48
Total Net profit including share of profit / Loss from associate company
23.07
40.69
31
34.7
39.48
28.04
21.17
28.83
57.48
EPS
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
67.57
Actual EPS
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
67.57
Adjusted EPS
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
67.57
Diluted EPS
27.12
47.84
36.44
40.79
46.41
32.96
24.88
33.89
67.57

Hester Biosciences Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
18.85
34.8
38.02
46.71
36.77
58.05
8.71
23.6
48.18
64.51
64.14
Cash Flow from Investing Activities
0.59
0.06
-2.82
1.61
0.86
-1.35
-21.07
0.82
1.95
1.08
-0.34
Cash Flow from Financing Activities
-6.69
1.83
-11.08
2.64
18.74
-18.23
111.55
41.75
-26.1
-51.72
-48.79
Net Cash Flow
-1.14
6.45
1.15
28.32
-17.12
-2.26
3.48
-11.59
-0.36
-6.72
-2.82

Hester Biosciences Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
53.73%
DII
0%
0%
0%
0.02%
0.02%
0.02%
0.02%
0%
0.01%
0%
0%
FII
0%
0.43%
0.52%
0.61%
0.59%
0.87%
0.52%
0.53%
0.51%
0.38%
0.31%
Public
45.84%
45.84%
45.74%
45.64%
45.65%
45.38%
45.73%
45.74%
45.75%
45.89%
45.95%
Total Outstanding Shares
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
85,06,865
Total Shareholders
13,450
12,844
11,305
11,538
11,473
11,853
11,810
12,260
12,603
12,373
11,961

Mutual Funds Buying / Exiting Hester Biosciences

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Hester Biosciences

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.01 Cr

₹0.00 Cr (+6.15%)

0.06%

Mutual Funds Exiting Hester Biosciences

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Hester Biosciences Corporate Actions

View detailed summary of the earnings and dividend history of Hester Biosciences.

  • Hester Biosciences Ltd Earnings Results

    Hester Biosciences Ltd’s net profit jumped 489.9% since last year same period to ₹96.98Cr in the Q1 2026-2027. On a quarterly growth basis, Hester Biosciences Ltd has generated 506.88% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Hester Biosciences Ltd Dividends May,2026

    In the quarter ending March 2026, Hester Biosciences Ltd has declared dividend of ₹11.00 per share on 15 May 2026 - translating a dividend yield of 0.49%.

    Read More about Dividends

Indices Featuring Hester Biosciences Stock

Check stock indices that include Hester Biosciences.

BSE Healthcare

₹50,383.20

-95.61 (▲0.19%)

Insights on Hester Biosciences Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 45.89% to 45.95% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 8.77 Cr → 96.98 Cr (in ₹), with an average increase of 64.3% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 79.4 Cr → 166.27 Cr (in ₹), with an average increase of 30.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 157.4% return, outperforming this stock by 129.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 53.73% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 45.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.38% to 0.31% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, HESTERBIO stock has moved down by -6.5%

About Hester Biosciences Ltd

Hester Pharmaceutical (HPL), established as a private limited company in April 1987 and transitioning to a public limited company in November of 1993, offers a range of veterinary and pharmaceutical products, such as animal health products, poultry vaccines, and laboratory kits and reagents. Furthermore, it markets the veterinary products of up to 10 international companies, including Ghen Corporation (Japan), Maine Biological Laboratories (US), Idexx Corporation (US), and Biogal Galed Laboratories (Israel). Entering the production of veterinary vaccines in vials, HPL also has technical collaborations with Maine Biological Laboratories and Ghen Corporation, and has since received licenses for producing an additional 10 poultry vaccines. To facilitate increased production, HPL has signed a manufacturing agreement with Sinsui Inc. for the production of additional poultry vaccines. Overall, HPL has continued to grow in the years since it was first established.

Revenue: ₹77.24Cr as on June 2026 (Q1 FY27)
Net Profit: ₹96.73Cr as on June 2026 (Q1 FY27)
Listing date: 13 Mar, 2015
OrganisationHester Biosciences Ltd
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Hester Biosciences share price today?

Hester Biosciences share price today stands at ₹2156.7 as on . Hester Biosciences share today touched a day high of ₹2222.5 and a low of ₹2130.

What is the 52 week high and 52 week low range for Hester Biosciences share?

Hester Biosciences touched a 52 week high of ₹2683.6 and a 52 week low of ₹1239.3. Hester Biosciences share price today i.e. is trending at ₹2156.7, which is -19.63% down from its 52 week high and 74.03% up from its 52 week low.

What is Hester Biosciences's market capitalisation today?

Hester Biosciences market capitalisation is ₹1,847.52 Cr as on .

How to buy Hester Biosciences shares?

To buy Hester Biosciences shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for HESTERBIO or Hester Biosciences Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Hester Biosciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Hester Biosciences trading volume today?

Hester Biosciences trading volume is 3,423.00 as on . This means that 3,423.00 shares of Hester Biosciences were bought and sold on the stock market during today's trading session.